2 completed, 1 recruiting, 1 unknown. 3 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Zoledronic acid 4 mg: new trials by email Literature Review of Zoledronic acid 4 mg trials Research Report on Zoledronic acid 4 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism | Phase 4 | Recruiting | University of Aarhus | 140 | 2025-03-01 | 2026-10-01 |
| Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole Zoledronic Acid 4 MG - Use of Zoledronic Acid in Breast Cancer | Phase 3 | Unknown | Assiut University | 50 | 2021-09-30 | 2021-12-21 |
| A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors Denosumab 70 mg/mL, Zoledronic acid 4 mg, Placebo IV - Fractures, Bone | Phase 3 | Completed | GlaxoSmithKline | 487 | 2013-08-01 | 2017-01-16 |
| A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) Zoledronic acid 4 mg - Non-Small-Cell Lung Cancer | Phase 3 | Completed | Novartis Pharmaceuticals | 437 | 2005-03-01 | 2015-05-04 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Fractures, Bone (1) · Hyperparathyroidism, Primary (1)
Assiut University (1) · GlaxoSmithKline (1) · Novartis Pharmaceuticals (1) · University of Aarhus (1)
China (2) · Taiwan (2) · Belgium (1) · Denmark (1) · Egypt (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Portugal (1) · Singapore (1) · South Korea (1)
2023 (1)